STOCK TITAN

ABEO (Nasdaq: ABEO) holder plans 20,070-share Rule 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of ABEO plans to sell 20,070 shares of common stock under Rule 144. The planned sale, through broker Stifel Nicolaus & Company Inc., has an aggregate market value of $102,168.00 and is listed for execution on or about 02/02/2026 on the Nasdaq.

The seller previously acquired 36,101 shares of common stock on 01/31/2026 via restricted stock units granted as equity compensation by the issuer and paid in equity rather than cash.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ABEO Rule 144 filing disclose?

The filing discloses that a shareholder plans to sell 20,070 ABEO common shares under Rule 144. The sale is through Stifel Nicolaus & Company Inc. on Nasdaq, with an aggregate market value of $102,168.00 based on the figures in the notice.

How many ABEO shares are planned to be sold and on what exchange?

The shareholder plans to sell 20,070 ABEO common shares on the Nasdaq. The filing lists Stifel Nicolaus & Company Inc. as broker and shows an aggregate market value of $102,168.00 for this planned transaction as of the notice.

How were the ABEO shares in the Rule 144 notice acquired?

The ABEO shares were acquired as restricted stock units granted by the issuer on 01/31/2026. The form shows 36,101 common shares acquired that day, with the nature of payment described as equity compensation instead of a cash purchase.

What is the aggregate market value of ABEO shares to be sold?

The planned sale of 20,070 ABEO common shares has an aggregate market value of $102,168.00. This value comes directly from the Rule 144 securities information table, which also identifies Nasdaq as the trading venue for the transaction.

How many ABEO shares are outstanding according to this notice?

The notice reports 54,191,361 ABEO common shares outstanding. This figure appears in the securities information table and serves as a baseline context for the planned 20,070-share Rule 144 sale listed in the same section of the document.

When is the approximate sale date for the ABEO Rule 144 transaction?

The approximate sale date for the ABEO shares is listed as 02/02/2026. This date appears in the securities information table alongside the 20,070 shares to be sold, the aggregate market value of $102,168.00, and Nasdaq as the named securities exchange.
Abeona Therapeut

NASDAQ:ABEO

ABEO Rankings

ABEO Latest News

ABEO Latest SEC Filings

ABEO Stock Data

278.00M
47.50M
5.78%
73.58%
17.61%
Biotechnology
Pharmaceutical Preparations
Link
United States
CLEVELAND